Literature DB >> 3156545

Midazolam: pharmacology and uses.

J G Reves, R J Fragen, H R Vinik, D J Greenblatt.   

Abstract

Midazolam is an imidazobenzodiazepine with unique properties when compared with other benzodiazepines. It is water soluble in its acid formulation but is highly lipid soluble in vivo. Midazolam also has a relatively rapid onset of action and high metabolic clearance when compared with other benzodiazepines. The drug produces reliable hypnosis, amnesia, and antianxiety effects when administered orally, intramuscularly, or intravenously. There are many uses for midazolam in the perioperative period including premedication, anesthesia induction and maintenance, and sedation for diagnostic and therapeutic procedures. Midazolam is preferable to diazepam in many clinical situations because of its rapid, nonpainful induction and lack of venous irritation. Compared with thiopental, midazolam is not as rapid acting nor predictable in hypnotic effect. It will not replace thiopental as an induction agent. Advantages of midazolam over thiopental are those of the more versatile pharmacologic properties of a benzodiazepine compared with a barbiturate such as amnestic and anxiolytic properties. Midazolam should be a useful addition to the formulary.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156545

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  154 in total

Review 1.  Sedation and analgesia in paediatric intensive care units: a guide to drug selection and use.

Authors:  J D Tobias
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  Percutaneous balloon kyphoplasty with the patient under intravenous analgesia and sedation: a feasibility study.

Authors:  M Mohr; D Pillich; M Kirsch; J U Mueller; S Fleck; N Hosten; S Langner
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

3.  Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.

Authors:  J W Mandema; E Tukker; M Danhof
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 4.  Pharmacodynamic considerations for moderate and deep sedation.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2012

5.  Rectal administration of midazolam versus diazepam for preanesthetic sedation in children.

Authors:  R Holm-Knudsen; T G Clausen; D Enø
Journal:  Anesth Prog       Date:  1990 Jan-Feb

6.  Anti-hypertensive therapy and risk factors associated with hypotension during colonoscopy under conscious sedation.

Authors:  Derek M Tang; Kellie Simmons; Frank K Friedenberg
Journal:  J Gastrointestin Liver Dis       Date:  2012-06       Impact factor: 2.008

7.  Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.

Authors:  Massimo Cella; Catherijne Knibbe; Saskia N de Wildt; Joop Van Gerven; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

8.  Relative potency and effectiveness of flunitrazepam, ethanol, and beta-CCE for disrupting the acquisition and retention of response sequences in rats.

Authors:  Stuart T Leonard; Lisa R Gerak; Marcus S Delatte; Joseph M Moerschbaecher; Peter J Winsauer
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

9.  Attenuation of reperfusion hyperalgesia in the rat by systemic administration of benzodiazepines.

Authors:  S M Cartmell; D Mitchell
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

10.  Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam.

Authors:  Wataru Ochiai; Hiroko Kobayashi; Satoshi Kitaoka; Mayumi Kashiwada; Yuya Koyama; Saho Nakaishi; Tomomi Nagai; Masaki Aburada; Kiyoshi Sugiyama
Journal:  J Nat Med       Date:  2018-03-17       Impact factor: 2.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.